Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).

@article{Roth2000Docetaxel,
  title={Docetaxel (Taxotere)-cisplatin (TC): an effective drug combination in gastric carcinoma. Swiss Group for Clinical Cancer Research (SAKK), and the European Institute of Oncology (EIO).},
  author={Arnaud D. Roth and Rudolf Maibach and Giovanna Martinelli and Nicola Fazio and Matti S. Aapro and Olivia Pagani and Rudolf Morant and Markus M. Borner and R Herrmann and Hanspeter Honegger and Franco Cavalli and Pierre Alberto and Mariane Castiglione and Aron Goldhirsch},
  journal={Annals of oncology : official journal of the European Society for Medical Oncology},
  year={2000},
  volume={11 3},
  pages={301-6}
}
PURPOSE A multi-centric trial was performed to explore the clinical activity, in terms of response and toxicity (primary objectives), duration of response and survival (secondary objectives), of docetaxel with cisplatin in advanced gastric cancer (AGC). PATIENTS AND METHODS Patients with measurable unresectable and/or metastatic gastric carcinoma, performance status < or = 1, normal hematological, hepatic and renal functions and not pretreated for advanced disease by chemotherapy received up… CONTINUE READING

Citations

Publications citing this paper.
Showing 1-10 of 89 extracted citations

References

Publications referenced by this paper.
Showing 1-10 of 39 references

5-FU as protracted continuous i.v. infusion (5-FUpiv) can be added to full dose Taxoterecisplatin (TC) in advanced gastric carcinoma (AGC)

AD Roth, R Maibach, N Fazio
Eur J Cancer [A] • 1999
View 1 Excerpt

Chemotherapy for advanced gastric cancer: where do we stand?

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1997
View 1 Excerpt

Phase I and pharmacologic study of docetaxel and cisplatin in patients with advanced solid tumors.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1997

Phase I trial of docetaxel and cisplatin in previously untreated patients with advanced non-small-cell lung cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1997
View 1 Excerpt

Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer.

Journal of clinical oncology : official journal of the American Society of Clinical Oncology • 1997
View 3 Excerpts

Similar Papers

Loading similar papers…